3-Methyl-1-(p-tolyl)-1H-pyrazol-5(4H)-one; 2,4-Dihydro-5-methyl-2-(4-methylphenyl)-3H-pyrazol-3-one; 3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-(4-methylphenyl)-; 1-(p-Tolyl)-3-methyl-5-pyrazolone; 5-methyl-2-(4-methylphenyl)-4H-pyrazol-3-one; 3-Methyl-1-p-tolyl-pyrazolin-5-one; 2-Pyrazolin-5-one, 3-methyl-1-p-tolyl-; 5-Methyl-2-(4-methylphenyl)-2,4-dihydro-3H-pyrazol-3-one; 3-Methyl-1-(p-tolyl)-2-pyrazolin-5-one; 3-methyl-1-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-5-one; Tolylmethylpyrazolone; EINECS 201-708-4; BRN 0610651; 2-Pyrazolin-5-one, 3-methyl-1-(4-methylphenyl)-; 5-methyl-2-(p-tolyl)-4H-pyrazol-3-one; 3-methyl-1-p-tolyl-1H-pyrazol-5(4H)-one; EC 201-708-4; ARONIS022638; SCHEMBL2203669; CHEMBL3740157; DTXSID6052588; IOQOLGUXWSBWHR-UHFFFAOYSA-; KS-00000VZC; HMS1668I09; ALBB-030571; KS-00004DU8; ZINC4747108; 1-(p-Tolyl)-3-methylpyrazolone-5; MFCD00035708; STK047562; AKOS000289051; METHYL5-AMINO-2-FLUOROBENZOATE; MCULE-2365174744; SDCCGMLS-0066222.P001; 3-Methyl-1-p-tolyl-5-pyrazolone,97%; AC-14556; ST021041; FT-0631410; M0554; 5-methyl-2-p-tolyl-2,4-dihydropyrazol-3-one; 5E-930; 3-methyl-1-(4-methylphenyl)-2-pyrazolin-5-one; 035M708; SR-01000467427; SR-01000467427-1; W-109315; Q27281606; 5-Methyl-2-(4-methylphenyl)-2,4-dihydro-3H-pyrazol-3-one #; 5-Methyl-2-(4-methylphenyl)-2,4-dihydro-3H-pyrazol-3-one, AldrichCPR